Zydus Lifesciences Rises 2% on Sterling Biotech Deal Update
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...
Tag : Baddi Facility
Morepen Laboratories gets USFDA nod for Baddi facility
Morepen Laboratories has received approval for its Baddi facility at Himachal Pradesh, from USFDA. The company’s Baddi facility has received approval for the manufacture of bulk drug Atorvastatin...